Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Mind Cure Health Inc
(OP:
MCURF
)
N/A
UNCHANGED
Last Price
Updated: 2:36 PM EDT, Sep 11, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mind Cure Health Inc
< Previous
1
2
3
Next >
Compass Pathways 2.0: A New Rally In Psychedelic Stocks?
November 04, 2021
Compass Pathways' IPO sparked a sector-wide rally in 2020. Now CMPS is on the move again. Is history about to repeat?
Via
Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
PsychedelicNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH), Provides Studies, Clinical Trials Update
November 04, 2021
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Product Safety
Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Growth Strategy Moves Forward with Awakn Life Sciences (NEO: AWKN) (OTCQB: AWKNF) Partnership for Ketamine-Assisted Psychotherapy Distribution
November 04, 2021
Via
Investor Brand Network
Increasing Prevalence of Depression & Mental Health Disorders Fueling Huge Growth in Psychedelic Drugs Market
November 04, 2021
Palm Beach, FL –November 4, 2021 – FinancialNewsMedia.com News Commentary – The pace of society’s change in attitude to the use of psychedelics has been amazing. It has gone from a “Born To Be Wild”,...
Via
FinancialNewsMedia
Topics
Law Enforcement
Exposures
COVID-19
Legal
MINDCURE Provides Update on Studies and Clinical Trials
November 04, 2021
Vancouver, BC – November 4, 2021 – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company“), a leader in advanced proprietary technology and research for psychedelics,...
Via
FinancialNewsMedia
Psyched: MindMed's MDMA Program For Autism, Small Pharma's New Patent, NovaMentis' Orphan Drug Designation
November 01, 2021
The Week In Psychedelics:
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
PsychedelicNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Enters Strategic LOI to Distribute Ketamine Protocol
October 28, 2021
Via
Investor Brand Network
MINDCURE Signs LOI with Awakn Life Sciences to Distribute Ketamine Protocol for Alcohol Use Disorder into Clinics Across United States and Canada through iSTRYM, MINDCURE’s Digital Therapeutics Platform
October 28, 2021
Vancouver, BC – October 28, 2021 – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company”), a leader in advanced proprietary technology and research for psychedelics,...
Via
FinancialNewsMedia
Developments with Ketamine Psychotherapy Are Driving A Medical Revolution For Treating Mental Health Issues
October 28, 2021
Palm Beach, FL –October 28, 2021 – FinancialNewsMedia.com News Commentary – Psychedelic drugs such as psilocybin, LSD and MDMA have tremendous medical and commercial future potential… and for ketamine,...
Via
FinancialNewsMedia
Topics
Death
Law Enforcement
Exposures
Death
Legal
PsychedelicNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) to Sponsor, Participate In Upcoming Events
October 27, 2021
Via
Investor Brand Network
BioMedNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Identifies Market Gap, Launches ‘Desire Project’
October 22, 2021
Via
Investor Brand Network
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
The Week In Psychedelics
Via
Benzinga
BioMedNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Focusing on What It Does Best
October 15, 2021
Via
Investor Brand Network
There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are
October 13, 2021
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors. S...
Via
Benzinga
Psychedelic Stocks: Financial Strength, Growth Potential, Compelling Valuations
October 12, 2021
Blue-chip stocks: grossly inflated valuations and loaded with debt. Psychedelic stocks: lean valuations and loaded with cash. A very attractive option in uncertain markets.
Via
Talk Markets
InvestorNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) to Present at KCSA Psychedelics Virtual Investor Conference
October 07, 2021
Via
Investor Brand Network
Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction
October 04, 2021
The Week In Psychedelics:
Via
Benzinga
BioMedNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Achieves Several Key Milestones in 2021
October 04, 2021
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Launches The Desire Project to Promote MDMA-Assisted Psychotherapy Treatment for HSDD
October 01, 2021
Via
Investor Brand Network
InvestorNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) Commences Trading on the OTCQX Best Market
September 30, 2021
Via
Investor Brand Network
BioMedNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) to Present at Benzinga Healthcare Small Cap Conference
September 28, 2021
Via
Investor Brand Network
Can MDMA (Or Ecstasy) Improve Sexual Desire in Women? MindCure Launches Research Program To Find Out
September 27, 2021
Mind Cure Health Inc. (CSE:MCUR) (OTCQB:
Via
Benzinga
BioMedNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) Announces Launch of the ‘Desire Project’
September 27, 2021
Via
Investor Brand Network
Is Ketamine A Psychedelic? Depends On Who You Ask
September 22, 2021
Ketamine, an FDA-approved anesthetic drug, has recently become the star of the psychedelic medicine movement. As p...
Via
Benzinga
InvestorNewsBreaks – Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) to be Included in AdvisorShares Psychedelics ETF
September 22, 2021
Via
Investor Brand Network
Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?
September 09, 2021
By Natan Ponieman and Javier Hasse The psychedelic medicine industry is growing by leaps and bounds. Leading this charge is a group of ambitious and visionary corporate...
Via
Benzinga
Psychedelic Drug Industry Report Card For 2021
September 01, 2021
In assessing the psychedelic drug industry, a primary focus for investors is drug development.
Via
Talk Markets
Psyched: Cybin Gets $9 Price Target, FSD Pharma Acquires Lucid, New Trials From Psilera, Awakn, PharmaDrug And Braxia, California Bill Put On Hold
August 30, 2021
Contents
Via
Benzinga
Which Psychedelic Drug Has The Most Commercial Potential?
August 10, 2021
As the Mental Health Crisis has become a mental health pandemic, clinical research on psychedelic drugs is showing that these substances are the best – and only – option to address this crisis.
Via
Talk Markets
How To Invest In "Magic Mushrooms" (Psychedelics)
July 09, 2021
A look at psychedelics as stock market investment opportunities and identifying alternative strategies on how to invest.
Via
Talk Markets
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.